Cargando…

Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of (18)F-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence

PURPOSE: To evaluate and compare the prognostic value of Epstein-Barr virus (EBV) DNA and maximal standard uptake values (SUV(max )) of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET) in subgroups of nasopharyngeal carcinoma (NPC) patients with locoregional or distant rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ting, Tang, Lin-Quan, Luo, Dong-Hua, Chen, Qiu-Yan, Li, Pei-Jing, Mai, Dong-Mei, Guo, Shan-Shan, Liu, Li-Ting, Qian, Chao-Nan, Guo, Xiang, Zeng, Mu-Sheng, Mo, Hao-Yuan, Mai, Hai-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390333/ https://www.ncbi.nlm.nih.gov/pubmed/25853677 http://dx.doi.org/10.1371/journal.pone.0122756

Ejemplares similares

Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake values of [(18)F]‐fluorodeoxyglucose positron emission tomography
por: Xie, Hao‐Jun, et al.
Publicado: (2020)

Maximal standard uptake values of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients
por: Sun, Xue-Song, et al.
Publicado: (2019)

Combining plasma Epstein-Barr virus DNA and nodal maximal standard uptake values of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography improved prognostic stratification to predict distant metastasis for locoregionally advanced nasopharyngeal carcinoma
por: Chen, Wen-Hui, et al.
Publicado: (2015)

Prognostic Value of Plasma Epstein–Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
por: Chen, Wen-Hui, et al.
Publicado: (2016)

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study
por: Liu, Sai-Lan, et al.
Publicado: (2019)

Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma
por: Qiu, Xiufang, et al.
Publicado: (2022)

Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy
por: Zhang, Lu, et al.
Publicado: (2015)

Plasma Epstein–Barr Viral Deoxyribonucleic Acid Predicts Worse Outcomes in Pediatric Nonmetastatic Nasopharyngeal Carcinoma Patients: An Observational Study of 89 Cases in an Endemic Area
por: Shen, Ting, et al.
Publicado: (2015)

Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zhang, Wan-Ru, et al.
Publicado: (2021)

Prognostic value of serum Epstein–Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein–Barr virus DNA
por: Yao, Ji‐Jin, et al.
Publicado: (2017)

TIGAR Is Correlated with Maximal Standardized Uptake Value on FDG-PET and Survival in Non-Small Cell Lung Cancer
por: Zhou, Xiang, et al.
Publicado: (2013)

Prognostic Value of Oral Epstein–Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma
por: He, Yong-Qiao, et al.
Publicado: (2022)

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
por: Liu, Li-Ting, et al.
Publicado: (2018)

Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study
por: Chen, Qiu-Yan, et al.
Publicado: (2018)

Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein–Barr virus DNA level after induction chemotherapy
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study
por: Chen, Qiu-Yan, et al.
Publicado: (2018)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
por: Looi, Chin King, et al.
Publicado: (2021)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
por: Li, You Quan, et al.
Publicado: (2018)

Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET
por: Lindholm, Henry, et al.
Publicado: (2014)

The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study
por: Yang, Zhen-Chong, et al.
Publicado: (2022)

Prognostic value of Epstein-Barr virus DNA load in nasopharyngeal carcinoma: a meta-analysis
por: Alami, Imane EL, et al.
Publicado: (2022)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
por: Liu, Sai-Lan, et al.
Publicado: (2020)

PET/CT standardized uptake value and EGFR expression predicts treatment failure in nasopharyngeal carcinoma
por: Fei, Zhaodong, et al.
Publicado: (2023)

Response to the hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-barr virus?
por: Xiao, Ruowen, et al.
Publicado: (2019)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer
por: Yoon, Hai-Jeon, et al.
Publicado: (2018)

Significance of FDG–PET standardized uptake values in predicting thyroid disease
por: Kikuchi, Tomohiro, et al.
Publicado: (2022)

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study
por: Guo, Shan-Shan, et al.
Publicado: (2016)

M1 stage subdivisions based on (18)F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma
por: Qiu, Hui-Zhi, et al.
Publicado: (2022)

Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA
por: Yuan, Xiaofei, et al.
Publicado: (2022)

Combining pretreatment plasma Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study
por: Du, Yu‐Yun, et al.
Publicado: (2019)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
por: Sun, Xue‐Song, et al.
Publicado: (2019)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
por: Zhu, Lisheng, et al.
Publicado: (2021)

Predictive significance of standardized uptake value parameters of FDG-PET in patients with non-small cell lung carcinoma
por: Duan, X-Y., et al.
Publicado: (2015)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Nasopharyngeal Epstein‐Barr virus DNA loads in high‐risk nasopharyngeal carcinoma families: Familial aggregation and host heritability
por: Zheng, Mei‐Qi, et al.
Publicado: (2020)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023)

Characterization of the Prognostic Values of CXCL Family in Epstein–Barr Virus Associated Gastric Cancer
por: Mu, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uafbouctmlbps5cmf4r5sho52p